China has witnessed a significant outbreak of a mysterious respiratory virus which has killed three people and has infected around 220 more. Such a scenario could give rise to the … Continue Reading China’s Mysterious Coronavirus is Spreading
A Global Switzerland Pharmaceutical, Novartis, has agreed to acquire Medicines Company (NASDAQ: MDCO) for a staggering $9.7 Billion. The Medicines Company, a biopharmaceutical company dedicated to the drug development of … Continue Reading Novartis Acquires The Medicines Company for $9.7 Billion
Dr. Tariq Rana and his colleagues discover a clue in stopping HIV cells from reproducing. A critical cellular player that controls HIV reproduction may be the key. What is HIV? … Continue Reading Can We Stop Infected HIV Cells from Replicating?
Transgene (TNG: FP), a French biotechnology company with the ambitious goal of taking oncolytic viruses to the market is facing a significant hurdle. A clinical trial reviewed by an independent … Continue Reading Transgene Stops Phase III Clinical Trial Deemed Useless
At first, you need to have a little introduction to these two companies. They both are pharmaceuticals. They provide medicines and research related to medicine. What are they and what … Continue Reading Mallinckrodt and Silence Therapeutics Partner up for RNAi
Crispr Pioneer Is Aiming Towards Brain Diseases In recent news, a CRISPR pioneer, Feng Zhang, from the Broad Institute of MIT and Harvard has started up his own pharma company. … Continue Reading Inventor of CRISPR, Feng Chang is Targeting Alzheimer’s
The biopharmaceutical business of Merck KGaA, EDM Serono, Darmstadt, Germany, announced that the United States Food and Drug Administration approved Bavencio, combined along with Inlyta, for the sake of the … Continue Reading Merck’s Bavencio Wins FDA Approval for Kidney Cancer, Setting up a Battle for Pharma Giants